Quantum Biopharma Income Statement (2018-2026) | QNTM

Income Statement Dec2018 Mar2019 Dec2019 Mar2020 Jun2020 Sep2020 Dec2020 Mar2021 Jun2021 Sep2021 Dec2021 Mar2022 Jun2022 Sep2022 Dec2022 Mar2023 Jun2023 Sep2023 Dec2023 Mar2024 Jun2024 Sep2024 Dec2024 Mar2025 Jun2025 Sep2025 Dec2025 Mar2026
Operating items
Research & Development (Quarter)
0.00B0.00B0.00B0.00B0.00B0.00B0.00B0.00B0.00B0.00B0.00B0.00B0.00B
Selling, General & Administrative (Quarter)
0.01B0.00B0.00B0.00B0.00B0.00B0.00B0.00B0.00B0.00B0.00B0.00B0.00B
Other Operating Expenses (Quarter)
0.00B0.00B0.00B0.00B0.00B0.00B0.00B0.00B
Operating Expenses (Quarter)
0.01B0.01B0.01B0.00B0.00B0.00B0.00B0.00B0.00B0.00B0.00B0.00B0.00B0.00B
Operating Income (Quarter)
-0.01B0.01B-0.01B0.03B-0.00B-0.01B-0.00B-0.00B-0.00B-0.00B-0.00B-0.00B-0.00B-0.00B-0.00B
EBIT (Quarter)
-0.01B0.01B-0.01B0.03B-0.00B-0.01B-0.00B-0.00B-0.00B-0.00B-0.00B-0.00B-0.00B-0.00B-0.00B
Non-operating items
Non Operating Investment Income (Quarter)
-0.00B-0.00B-0.00B-0.00B-0.00B0.00B-0.00B0.00B-0.00B-0.00B-0.00B0.00B
Other Non Operating Income (Quarter)
-0.00B-0.00B0.00B0.00B-0.00B0.00B0.00B74.000.00B0.00B0.00B0.00B-0.02B0.01B
Non Operating Income (Quarter)
0.00B380.00-0.00B
Net income details
EBT (Quarter)
-0.01B0.01B-0.01B0.03B-0.00B-0.01B-0.00B-0.00B-0.00B-0.00B-0.00B-0.00B-0.00B-0.00B-0.00B
Profit After Tax (Quarter)
-0.01B0.05B-0.06B0.01B0.01B0.01B-0.05B-0.01B0.01B0.00B-0.03B-0.00B0.00B0.00B-0.00B-0.01B-0.00B-0.00B-0.00B-0.00B
Equity Income (Quarter)
0.00B
Income from Non-Controlling Interests (Quarter)
-0.01B0.01B-0.01B0.03B-0.00B-0.03B-0.00B-0.00B0.00B-0.01B-0.01B0.01B-0.00B-0.00B-0.01B
Income from Continuing Operations (Quarter)
-0.01B0.01B-0.01B0.03B-0.00B-0.01B-0.00B-0.00B-0.00B-0.00B-0.00B-0.00B-0.00B-0.00B-0.00B
Consolidated Net Income (Quarter)
-0.00B-0.00B-0.01B0.03B-0.00B-0.01B-0.00B-0.00B-0.00B-0.00B-0.00B-0.00B-0.00B-0.00B-0.00B
Income towards Parent Company (Quarter)
-0.00B-0.00B-0.01B-0.01B-0.00B-0.01B-0.00B-0.00B-0.00B-0.00B-0.01B-0.01B-0.01B-0.00B-0.01B
Net Income towards Common Stockholders (Quarter)
-0.00B-0.00B-0.01B-0.01B-0.00B-0.01B-0.00B-0.00B-0.00B-0.00B-0.01B-0.01B-0.01B-0.00B-0.01B
Additional items
EPS (Basic) (Quarter)
-0.35-0.150.14-0.21-0.19-0.26-0.14-0.03-0.053.430.08-4.37-0.013.533.231.250.003.06
EPS (Weighted Average and Diluted) (Quarter)
0.000.000.00-14.08-0.04-0.55-23.94-0.35-2.43-1.37-0.71-0.70-4.43
Shares Outstanding (Weighted Average) (Quarter)
0.00B0.14B38,962.42B0.00B0.03B0.14B610.03B0.15B917.85B0.15B2,474.97B151.70B151.70B169,551.04B177,333.76B
Shares Outstanding (Diluted Average) (Quarter)
35,991.92B36,296.05B0.03B39,998.79B39,234.86B38,888.15B38,962.42B0.00B0.03B0.00B0.00B0.01B0.00B0.01B0.01B0.00B0.00B
EBITDA (Quarter)
-0.01B0.01B-0.01B0.03B-0.00B-0.01B-0.00B-0.00B-0.00B-0.00B-0.01B-0.01B-0.00B-0.00B-0.01B
Interest Expenses (Quarter)
0.00B0.00B0.00B0.00B-0.00B0.00B0.00B-0.00B0.00B0.00B0.00B0.00B0.00B0.00B0.00B-0.00B0.00B